SPECIFIC CHANGES IN SKELETAL-MUSCLE MYOSIN HEAVY-CHAIN COMPOSITION INCARDIAC-FAILURE - DIFFERENCES COMPARED WITH DISUSE ATROPHY AS ASSESSED ON MICROBIOPSIES BY HIGH-RESOLUTION ELECTROPHORESIS
G. Vescovo et al., SPECIFIC CHANGES IN SKELETAL-MUSCLE MYOSIN HEAVY-CHAIN COMPOSITION INCARDIAC-FAILURE - DIFFERENCES COMPARED WITH DISUSE ATROPHY AS ASSESSED ON MICROBIOPSIES BY HIGH-RESOLUTION ELECTROPHORESIS, HEART, 76(4), 1996, pp. 337-343
Objective-In congestive heart failure (CHF) the skeletal muscle of the
lower limbs develops a myopathy with atrophy and shift from the slow
type to the fast type fibres. The aim was to test the hypothesis that
this myopathy is specific and not simply related to detraining, by com
paring patients with different degrees of CHF with patients with sever
e muscle atrophy due to disuse. Design-Case-control study involving 50
-150 mu g needle biopsies of the gastrocnemius muscle. By an electroph
oretic micromethod, the three isoforms of myosin heavy chains (MHC) we
re separated. Patients-Five patients restricted to bed for more than o
ne year because of stroke with disuse atrophy and normal ventricular f
unction, and 19 with CHF were studied. There were seven age matched co
ntrols. Main outcome measures-The percentage of MHC1 (slow isoform), M
HC2a (fast oxidative), and MHC2b (fast glycolytic) was determined by d
ensitometric scan and correlated with indices of severity of cardiac f
ailure. Results-Ejection fraction was 42.5 (SD 15.2)% in CHF, 59.5 (1.
0)% in disuse atrophy and 60.3 (1.4)% in controls (P < 0.001 v both).
The degree of muscle atrophy as calculated by the body mass index/gast
rocnemius cross sectional area, showed a profound degree of atrophy in
patients with muscle disuse [0.94 (0.39)]. This was worse than in the
controls [4.27 (0.16), P < 0.0005] and the CHF patients [2.60 (1.10),
P < 0.005]. Atrophy in CHF patients was also greater than in controls
(P < 0.005). MHC1 was lower in CHF than in disuse atrophy [51.83 (15.
04) v 84.5 (17.04), P < 0.01] while MHC2b was higher [23.5 (7.4) v 7.2
5 (7.92), P < 0.001]. There was a similar trend for MHC2a [24.83 (15.0
1) v 8.25 (9.12), P < 0.05]. Within the CHF group there was a positive
correlation between NYHA class and MHC2a (r = 0.47, P < 0.05) and MHC
2b (r = 0.55, P < 0.01) and a negative correlation between NYHA class
and MHC1 (r = - 0.74, P < 0.001). Similarly, significant correlations
were found for ejection fraction, diuretic consumption score, exercise
test tolerance, and degree of muscle atrophy. Conclusions-The CHF myo
pathy appears to be specific and not related to detraining. The magnit
ude of MCH redistribution correlates with the severity of the disease.
The electrophoretic micromethod used is very sensitive and reproducib
le. Biopsies are so well tolerated that can be repeated frequently, al
lowing thorough follow up.